Standard Orbitozygomatic Craniotomy versus Mini Orbitozygomatic Craniotomy via an Eyebrow Incision for Microsurgical Treatment of Anterior Communicating Artery Aneurysms
Journal of Neurological Surgery Part B: Skull Base · 01.08.2024 · 85 (04) · 431-437
DOI: 10.1055/a-2065-6021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.08.2024. Verfasst von David R Peters und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Atrium Health's Carolinas Medical Center, Charlotte, North Carolina, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Skull base approaches are utilized to improve microsurgical treatment of cerebral aneurysms. Advantages include early proximal and distal control, increased visualization, and minimal brain retraction. Orbitozygomatic (OZ) craniotomies via pterional incision are commonly used for the treatment of anterior communicating artery (ACoA) aneurysms. A smaller, less invasive OZ craniotomy performed through an eyebrow incision may provide several advantages over a standard OZ approach.
Objective
We compare surgical outcomes of the standard and eyebrow OZ for the treatment of ACoA aneurysms.
Design
All patients who underwent microsurgical treatment for ACoA aneurysms by a single surgeon over an 8-year period were included in this retrospective analysis. Patient demographics and clinical data were collected.
Participants
Thirty-seven consecutive patients were identified, with 15 receiving eyebrow OZ and 22 receiving standard OZ. Main Outcome Measures Data were collected on patient demographics, pathology, intraoperative and perioperative data, and 30-day morbidity.
Results
A total of 100% of the eyebrow OZ group and 95.5% of the standard OZ group had complete aneurysmal occlusion. Four eyebrow OZ and six standard OZ patients had an intraoperative rupture. All were managed without complication. Two eyebrow OZ and one standard OZ patient died within 30 days of surgery. No patients in either group had aneurysm recurrence, required retreatment, or were limited intraoperatively by exposure.
Conclusions
The OZ approach via an eyebrow incision has similar outcomes to a standard OZ approach and is a safe option for the treatment of ACoA aneurysms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Atrium Health's Carolinas Medical Center, Charlotte, North Carolina, United States.
- Carolina Neurosurgery and Spine Associates, Charlotte, North Carolina, United States.
- Brody School of Medicine, East Carolina University, Greenville, North Carolina, United States.
- Department of Pediatric Neurosurgery, Levine Children's Hospital, Charlotte, North Carolina, United States.
ORCID-Profile: David R Peters
Zitieren
APA
Peters, D. R., Mulvaney, G., Monk, S., Karimian, B., & Wait, S. D. (2024). Standard Orbitozygomatic Craniotomy versus Mini Orbitozygomatic Craniotomy via an Eyebrow Incision for Microsurgical Treatment of Anterior Communicating Artery Aneurysms. Journal of Neurological Surgery Part B: Skull Base, 85(04), 431-437. https://doi.org/10.1055/a-2065-6021
Vancouver
Peters DR, Mulvaney G, Monk S, Karimian B, Wait SD. Standard Orbitozygomatic Craniotomy versus Mini Orbitozygomatic Craniotomy via an Eyebrow Incision for Microsurgical Treatment of Anterior Communicating Artery Aneurysms. Journal of Neurological Surgery Part B: Skull Base. 2024;85(04):431-437. doi:10.1055/a-2065-6021
BibTeX
@article{Peters2024,
author = {Peters, David R and Mulvaney, Graham and Monk, Steve and Karimian, Brandon and Wait, Scott D},
title = {Standard Orbitozygomatic Craniotomy versus Mini Orbitozygomatic Craniotomy via an Eyebrow Incision for Microsurgical Treatment of Anterior Communicating Artery Aneurysms},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {04},
pages = {431--437},
doi = {10.1055/a-2065-6021}
}
EUVIMED